Retail and E-commerce

Primary Sclerosing Cholangitis Market Economic Outlook, Structure Analysis forecast by 2026

Triddha Agarwal

Market Analysis: Global Primary Sclerosing Cholangitis Market

Primary Sclerosing Cholangitis Market is expected to rise gradually to an estimated value of USD 157.13 million by 2026, registering a CAGR of 3.7% in the forecast period of 2019-2026 with the annual sales of USD 117.5 million in the year of 2018. This rise in market value can be attributed to the increasing awareness and concerns regarding the health of patients.

Market Definition: Global Primary Sclerosing Cholangitis Market

Primary Sclerosing Cholangitis (PSC) is a chronic cholestatic disease of the liver which is characterized by progressive inflammation, fibrosis, and stricturing of the intrahepatic and extrahepatic bile ducts. It is progressive in most patients and leads to cirrhosis.

According to a study of NCBI, there were approximately 0.2 - 1.2 million people having primary sclerosing cholangitis as of 2018, in Northern European countries and North America where the disease is most common, almost more than half of these cases could have been avoided with the availability of proper medical treatment. This significant number is expected to act as a driver to the market growth.

Get More Insights About Global Primary Sclerosing Cholangitis Market, Request Sample @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-primary-sclerosing-cholangitis-market

Market Drivers

Rise in incidence and prevalence rate of liver failure and bile cancer associated with PSC.
Large No. of pipeline molecules is expected to drive the growth of the market.

Market Restraints

Withdrawal of novel molecules from late stage clinical trials will restrain the growth of the market.
Organ transplantation remains the alternative which is associated with many risk factors like relapse of the disease.
Lack of skilled expertise in remote areas
Fewer Government initiatives taken in this direction.

Segmentation: Global Primary Sclerosing Cholangitis Market

By Type

Classic PSC
Small-duct PSC
PSC associated with autoimmune hepatitis

By Treatment Type

Ursodeoxycholic acid
Obeticholic Acid
Methotrexate
Corticosteroids
Others

By Symptom Control

Antihistamines
Cholestyramine
Antibacterials
Opioid Antagonists
Colestipol
Others

By End- User

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Geography

North America

US.
Canada
Mexico

South America

Brazil
Argentina
Rest of South America

Europe

Germany
France
United Kingdom
Italy
Spain
Russia
Turkey
Belgium
Netherlands
Switzerland
Rest of Europe

Asia-Pacific

Japan
China
South Korea
India
Australia
Singapore
Thailand
Malaysia
Indonesia
Philippines
Rest of Asia Pacific

Middle East & Africa

South Africa
Egypt
Saudi Arabia
United Arab Emirates
Israel
Rest of Middle East & Africa

Know more about this report https://www.databridgemarketresearch.com/reports/global-primary-sclerosing-cholangitis-market

Key Developments in the Market:

On 19^th January, 2016, Acorda Therapeutics, Inc. announced that it entered into an agreement to acquire Biotie Therapies Corp. According to the agreement, the company will acquire the four pipeline products that include BTT1023, a fully human monoclonal antibody in Phase 2 development for treatment of primary sclerosing cholangitis (PSC) which will help company to grow.
On 27^th March, 2019, Gilead Sciences, Inc. announced the company’s research and development programs in primary sclerosing cholangitis (PSC) will be presented at The International Liver Congress™ 2019 in Vienna. Currently the novel molecule, Cilofexor has not get the approval but once it gets approval it will generate the revenue for the company and contribute towards the growth of the market.

Competitive Analysis: Global Primary Sclerosing Cholangitis Market

Global primary sclerosing cholangitis market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of primary sclerosing cholangitis market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Market Competitors: Global Primary Sclerosing Cholangitis Market

Few of the major competitors currently working in the primary sclerosing cholangitis market are Acorda Therapeutics, Inc. (US), Gilead Sciences, Inc. (US), NGM Biopharmaceuticals (US), Intercept Pharmaceuticals, Inc. (US), Dr. Falk Pharma GmbH (Germany), ALLERGAN (Ireland), Takeda Pharmaceutical Company Limited. (Japan), DURECT CORPORATION (US), Conatus Pharmaceuticals, Inc. (US), Sirnaomics, Inc. (US), and HighTide Therapeutics Inc. (China), Glenmark (India), Impax Laboratories, LLC (US), Mylan N.V. (US), Teva Pharmaceuticals Industries Ltd. (Israel) and few among others.

Get Access Report @ https://www.databridgemarketresearch.com/checkout/buy/singleuser/global-primary-sclerosing-cholangitis-market

Research Methodology: Global Primary Sclerosing Cholangitis Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more please Request an Analyst Call or can drop down your inquiry.

The key research methodology used by DBMR Research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Request for Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-primary-sclerosing-cholangitis-market

Browse Trending Related Reports @

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: [email protected]

Triddha Agarwal

Quality Audit –Types and Procedures

PHARMALANE UK 2022-03-24

In the pharmaceutical company or industry, audits are regarded as virtual means of evaluating compliance with the specified objectives as defined in the dedicated quality system. As such, quality audits in the pharma sector pave a path of ensuring continuous improvement by offering relevant feedback to the management. External Audit: This type of audit is carried out for the suppliers or outsourcing operations in the pharmaceutical industry. ConclusionQuality audit in the pharmaceutical industry plays a vital role in determining the efficiency of the entire set of processes involves. It should only be carried out under the supervision of professional pharmaceutical service providers.

Revolutionizing Pharmaceutical Development: Exploring the Potential of Pharmaceutical Formulation Software

SG Systems Global 2023-08-22

In this pursuit, Pharmaceutical Formulation Software has emerged as a game-changing tool, streamlining the process of drug formulation and significantly enhancing the efficiency of pharmaceutical research and development. Enter Pharmaceutical Formulation SoftwarePharmaceutical Formulation Software is a sophisticated technological solution designed to facilitate the formulation process through data analysis, modeling, and simulation. Key Features and Benefits· Predictive Modeling: Pharmaceutical Formulation Software utilizes predictive models based on physicochemical properties, aiding researchers in understanding how various components interact and influence the drug's behavior. Real-Life Applications Pharmaceutical Formulation Software has found application across a wide range of drug development areas, including:· Novel Drug Development: Accelerating the formulation of new chemical entities, improving the likelihood of identifying viable drug candidates. In a field where every advancement directly impacts human health, Pharmaceutical Formulation Software stands as a beacon of efficiency, accuracy, and innovation.

Pinnacle 3 pharmaceuticals in Mumbai

RVD Tutors 2020-09-17

The pharmaceutical enterprise in developing.

Mumbai has been plenty in the discussion for its improvement in pharmaceutical works.

There are well-known pharmaceutical companies in Mumbai which supply drug treatments and system to many places of the country as well as outside the united states of America.

Pharmaceutical Traceability: Ensuring Patient Safety Throughout the Supply Chain

Sneha 2024-02-27

The global pharmaceutical supply chain is complex with products changing hands multiple times before reaching patients. With such an intricate network in place, ensuring the authenticity and integrity of medicines at each step is challenging but critical for patient safety. What is Pharmaceutical Traceability? This identifier is then linked to relevant transaction data throughout the supply chain in an electronic database. With a strong commitment and the right digital solutions, the sector can certainly achieve comprehensive traceability to reinforce patient safety worldwide.

What is the Uniqueness of a Pharmaceutical Company?

Anku Rastogi 2022-09-16

The pharmaceutical industry is one of the critical and essential industries in the world. The Significance of the Pharmaceutical Industry The pharmaceutical industry is one of the most dynamic, volatile, and innovative parts of the global economic environment. Applications in the Pharmaceutical Industry Biopharmaceutical products are medicinal products that are manufactured through the use of biotechnology. A skilled workforce and infrastructure are the main features of the pharmaceutical industry. Large Market- Pharmaceutical industry has a large market due to its extensive quality.

Regulatory Reforms In The Pharmaceutical Industry Are Promoting Innovative Business-Models

Ingenious E-Brain Solutions 2023-01-19

The pharmaceutical industry is a boon to any country for its commitment towards the alleviation of chronic/non-chronic diseases by new chemical entities or generics. Providing solutions for these challenges requires extensive knowledge of the subject matter apart from expertise in executing various IP & technology intelligence projects. The team comprises experts with an impeccable blend of subject knowledge, industry R&D, IP experience, and market expertise. Ingenious e-Brain Solutions has a strong team of analysts, and subject matter experts with domain proficiency which is devoted to help clients grow. Get in Touch: -India Office207-208 Welldone TechPark, Sohna RoadSector 48, Gurugram, Haryana 122018, India+91 124 429 4218Email: -queries@iebrain.

WHO TO FOLLOW